Table 1 Baseline characteristics before and after matching by treatment
Paroxysmal AF patients | Persistent AF patients | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Before matching (n/N) | After matching (n/N) | Before matching (n/N) | After matching (n/N) | |||||||||
Characteristics | Ablation | Drug | Sig. | Ablation | Drug | Sig. | Ablation | Drug | Sig. | Ablation | Drug | Sig. |
Age (≥75 yrs) | 5.33% (4/75) | 17.90% (29/162) | * | 5.33% (4/75) | 5.33% (4/75) | 26.32% (20/76) | 57.69% (90/156) | * | 35.09% (20/57) | 35.09% (20/57) | ||
Sex (Male) | 57.33% (43/75) | 59.26% (96/162) | 57.33% (43/75) | 62.67% (47/75) | 73.68% (56/76) | 57.69% (90/156) | * | 68.42% (39/57) | 57.89% (33/57) | |||
BMI (≥25) | 49.33% (37/75) | 51.23% (83/162) | 49.33% (37/75) | 56.00% (42/75) | 76.32% (58/76) | 53.21% (83/156) | * | 68.42% (39/57) | 68.42% (39/57) | |||
Coronary Atherosclerotic Heart Disease (yes) | 10.67% (8/75) | 16.67% (27/162) | 10.67% (8/75) | 16.00% (12/75) | 5.26% (4/76) | 19.23% (30/156) | * | 3.51% (2/57) | 3.51% (2/57) | |||
NYHABA (>Level I) | 6.67% (5/75) | 12.35% (20/162) | 6.67% (5/75) | 6.67% (5/75) | 2.63% (2/76) | 9.62% (15/156) | 3.51% (2/57) | 3.51% (2/57) | ||||
Other Arrhythmia (yes) | 10.67% (8/75) | 4.94% (8/162) | 10.67% (8/75) | 5.33% (4/75) | 2.63% (2/76) | 2.56% (4/156) | 3.51% (2/57) | 1.75% (1/57) | ||||
Hypertension (yes) | 60.00% (45/75) | 59.88% (97/162) | 60.00% (45/75) | 62.67% (47/75) | 56.58% (43/76) | 50.00% (78/156) | 56.14% (32/57) | 45.61% (26/57) | ||||
Thrombotic diseases (yes) | 13.33% (10/75) | 15.43% (25/162) | 13.33% (10/75) | 17.33% (13/75) | 9.21% (7/76) | 15.38% (24/156) | 12.28% (7/57) | 17.54% (10/57) | ||||
Diabetes (yes) | 13.33% (10/75) | 17.28% (28/162) | 13.33% (10/75) | 20.00% (15/75) | 10.53% (8/76) | 14.74% (23/156) | 10.53% (6/57) | 17.54% (10/57) | ||||
Bleeding (yes) | 2.67% (2/75) | 2.47% (4/162) | 2.67% (2/75) | 1.33% (1/75) | 1.32% (1/76) | 3.21% (5/156) | 1.75% (1/57) | 1.75% (1/57) | ||||
Chronic Bronchitis and Chronic Obstructive Pulmonary Disease (yes) | 0.00% (0/75) | 8.02% (13/162) | * | 0.00% (0/75) | 10.67% (8/75) | * | 2.63% (2/76) | 7.69% (12/156) | 3.51% (2/57) | 7.02% (4/57) | ||
Hyperthyroidism (yes) | 1.33% (1/75) | 0.62% (1/162) | 1.33% (1/75) | 1.33% (1/75) | 98.68% (75/76) | 95.51% (149/156) | 98.25% (56/57) | 94.74% (54/57) | ||||
Education (High School or less) | 48.00% (36/75) | 54.32% (88/162) | 48.00% (36/75) | 61.33% (46/75) | 43.42% (33/76) | 70.51% (110/156) | * | 57.89% (33/57) | 57.89% (33/57) | |||
Insurance Status | ||||||||||||
1 | 86.67% (65/75) | 88.27% (143/162) | 86.67% (65/75) | 85.33% (64/75) | 92.11% (70/76) | 85.26% (133/156) | 92.98% (53/57) | 84.21% (48/57) | ||||
2 | 13.33% (10/75) | 11.73% (19/162) | 13.33% (10/75) | 14.67% (11/75) | 7.89% (6/76) | 14.74% (23/156) | 7.02% (4/57) | 15.79% (9/57) | ||||
Monthly Family Total Income | ||||||||||||
< 2000 | 0.00% (0/75) | 6.17% (10/162) | 0.00% (0/75) | 5.33% (4/75) | 3.95% (3/76) | 3.85% (6/156) | 3.51% (2/57) | 5.26% (3/57) | ||||
2000–5000 | 37.33% (28/75) | 27.16% (44/162) | 37.33% (28/75) | 34.67% (26/75) | 26.32% (20/76) | 33.97% (53/156) | 31.58% (18/57) | 28.07% (16/57) | ||||
5000–10,000 | 44.00% (33/75) | 40.74% (66/162) | 44.00% (33/75) | 42.67% (32/75) | 40.79% (31/76) | 33.33% (52/156) | 40.35% (23/57) | 28.07% (16/57) | ||||
> 10,000 | 18.67% (14/75) | 25.93% (42/162) | 18.67% (14/75) | 17.33% (13/75) | 28.95% (22/76) | 28.85% (45/156) | 24.56% (14/57) | 38.60% (22/57) | ||||
Family Monthly Income (RMB) | ||||||||||||
< 1000 | 1.33% (1/75) | 6.79% (11/162) | 1.33% (1/75) | 6.67% (5/75) | 3.95% (3/76) | 3.21% (5/156) | 3.51% (2/57) | 5.26% (3/57) | ||||
1000–2500 | 36.00% (27/75) | 29.01% (47/162) | 36.00% (27/75) | 34.67% (26/75) | 27.63% (21/76) | 36.54% (57/156) | 35.09% (20/57) | 29.82% (17/57) | ||||
2500–5000 | 53.33% (40/75) | 52.47% (85/162) | 53.33% (40/75) | 54.67% (41/75) | 51.32% (39/76) | 44.23% (69/156) | 45.61% (26/57) | 36.84% (21/57) | ||||
> 5000 | 9.33% (7/75) | 11.73% (19/162) | 9.33% (7/75) | 4.00% (3/75) | 17.11% (13/76) | 16.03% (25/156) | 15.79% (9/57) | 28.07% (16/57) | ||||